Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: IGF-1 Monitoring in Children Treated With NutropinAq
NCT00234533Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jun 2004
- Primary completion
- Jul 2008
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 14
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), Turner syndrome (TS), chronic kidney disease (CKD), sponsored by Ipsen. Started Jun 2004; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)Turner syndrome (TS)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00234533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234533.